The NHLBI is hosting the 3rd Systems Biology Symposium on May 12-13, 2021. The purpose of the 2-day virtual conference is to continue an ongoing interactive forum to discuss and advance the understanding of systems biology and its translational applications; review emerging systems biology technologies including imaging, proteomics, epigenomics, single-cell genomics and related computation methods; provide a forum for interaction and collaboration at an international meeting.
This meeting supports NHLBI's mission by allowing a collaborative research partnership to promote the application of research results to address public health needs and reduce the burden of heart, lung, and blood diseases worldwide. We will be able to highlight the presence and accomplishments of numerous systems biology laboratories within the DIR, NHLBI by providing a forum to present their work and stimulate potential for new research opportunities within the DIR.
This event is free and open to the public, though registration is required. A reminder will be sent prior to the meeting that will include a Zoom URL.
The call for abstracts has now ended.
Robert Balaban, Ph.D., National Heart, Lung, and Blood Institute, NIH
Hugo Bellen, D.V.M, Ph.D., Baylor College of Medicine
Edward Boyden, Ph.D., Massachusetts Institute of Technology
Long Cai, Ph.D., California Institute of Technology
Jeffrey Farrell, Ph.D., National Institute of Child Health and Human Development, NIH
Brian Glancy, Ph.D., National Heart, Lung, and Blood Institute, NIH
Anna Greka, M.D., Ph.D., Massachusetts Institute of Technology
Susan Harbison, Ph.D., National Heart, Lung, and Blood Institute, NIH
Harald Hess, Ph.D., Howard Hughes Medical Institute
Mark Knepper, M.D., Ph.D., National Heart, Lung, and Blood Institute, NIH
Norbert Perrimon, Ph.D., Harvard Medical School / Howard Hughes Medical Institute
Susan Redline, M.D., M.P.H., Harvard Medical School
Gary Siuzdak, Ph.D., Scripps Center for Metabolomics
Katalin Susztak, M.D., Ph.D., University of Pennsylvania Perelman School of Medicine
Xiaoliang Sunney Xie, Ph.D., Peking University
Hong Xu, Ph.D., National Heart, Lung, and Blood Institute, NIH
Richard Young, Ph.D., Massachusetts Institute of Technology
Keji Zhao, Ph.D., National Heart, Lung, and Blood Institute, NIH
Sign language interpreting services are available for all NIH events, upon request. Individuals with disabilities who need Sign Language Interpreters and/or reasonable accommodation to participate in this event should contact the event organizer at firstname.lastname@example.org. Requests should be made no later than April 30, 2021.